Withdrawal Notice: Targeting lncRNAs for Cardiovascular Therapeutics in Coronary Artery Disease

Title:Withdrawal Notice: Targeting lncRNAs for Cardiovascular Therapeutics in Coronary Artery Disease

Volume: 24

Author(s): Dongsheng Yu, Chuanfeng Tang, Peiyu Liu, Weichun Qian* Liang Sheng

Affiliation:

• Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing,China

Abstract: The article has been withdrawn at the request of the author of the journal Current Pharmaceutical Design CPD:

Bentham Science apologizes to the readers of the journal for any inconvenience this may cause.

Bentham Science Disclaimer:
It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.

Cite this article as:

Yu Dongsheng, Tang Chuanfeng, Liu Peiyu, Qian Weichun*, Sheng Liang, Withdrawal Notice: Targeting lncRNAs for Cardiovascular Therapeutics in Coronary Artery Disease, Current Pharmaceutical Design 2018; 24 () . https://dx.doi.org/10.2174/1381612824666180108120727